Background Asthma and obliterative bronchiolitis (OB) cases have occurred among styrene-exposed workers. We aimed to investigate styrene as a risk factor for non-malignant respiratory disease (NMRD). Methods From a literature review, we identified case reports and assessed cross-sectional and mortality studies for strength of evidence of positive association (i.e., strong, intermediate, suggestive, none) between styrene exposure and NMRD-related morbidity and mortality. Results We analyzed 55 articles and two unpublished case reports. Ten OB cases and eight asthma cases were identified. Six (75%) asthma cases had abnormal styrene inhalation challenges. Thirteen (87%) of 15 cross-sectional studies and 12 (50%) of 24 mortality studies provided at least suggestive evidence that styrene was associated with NMRD-related morbidity or mortality. Six (66%) of nine mortality studies assessing chronic obstructive pulmonary disease-related mortality indicated excess mortality. Conclusions Available evidence suggests styrene exposure is a potential risk factor for NMRD. Additional studies of styrene-exposed workers are warranted.
INTRODUCTION
Asthma and obliterative bronchiolitis (OB) cases have occurred among workers exposed to styrene [Moscato et al., 1987; Cullinan et al., 2013] . OB is a rare and irreversible lung disease often associated with exposure to inhalational toxins, and frequently characterized by a short latency and insidious onset of dyspnea, non-productive cough, and airway obstruction [Epler, 2007; Kreiss, 2013; Barker et al., 2014; Cummings and Kreiss, 2015] . We sought to assess the available evidence for the risk of non-malignant respiratory disease (NMRD) among workers in industries using styrene.
Styrene (C 8 H 8 ) is a colorless liquid and volatile organic compound that occurs naturally in small quantities in certain plants and foods [Agency for Toxic Substances & Disease Registry, 2012] . Commercially produced since the 1920s, styrene is an important industrial component used in the manufacturing of reinforced plastics and synthetic rubbers [International Agency for Research on Cancer, 2002] . Industries that commonly use styrene include boat and automobile manufacturing, plastics, food packaging, wind energy, and others [Agency for Toxic Substances & Disease Registry, 2010; Styrene Information & Research Center, 2014; McCague et al., 2015] . In 2008, over 12 billion pounds of styrene were produced in the United States [Agency for Toxic Substances & Disease Registry, 2010 ].
An estimated 90,000 U.S. workers are potentially exposed to styrene [Occupational Safety & Health Administration, 2016] . Work-related exposure most commonly occurs through inhalation and skin contact [Agency for Toxic Substances & Disease Registry, 2010] . The amount of styrene workers are exposed to varies by industry, job, presence of environmental controls, and use of personal protective equipment. The Occupational Safety and Health Administration (OSHA) permissible exposure limit over an 8-hr time-weighted average (TWA) is 100 ppm, the National Institute for Occupational Safety and Health (NIOSH) recommended exposure limit is 50 ppm, and the American Conference of Governmental Industrial Hygienists (ACGIH) [2015] threshold limit value for an 8-hr TWA is 20 ppm [Agency for Toxic Substances & Disease Registry, 2010] . The NIOSH recommended short-term exposure limit over a 15-min TWA is 100 ppm. The highest levels of occupational exposure to styrene have occurred when glass-fiber-reinforced plastics are used in the production of automotive parts, bathtubs, boats, and tanks [National Toxicology Program, 2014] . Occupational exposure to styrene has been associated with deleterious health effects, including mucous membrane irritation, changes in color vision, hearing loss, and neurocognitive impairment [Benignus et al., 2005 ; Agency for Toxic Substances & Disease Registry, 2010; Morata et al., 2011] . In addition, the International Agency for Research on Cancer [2002] classifies styrene as possibly carcinogenic to humans, and the National Toxicology Program [2014] classifies styrene as reasonably anticipated to be a human carcinogen.
Styrene toxicology studies support the biological plausibility of styrene-induced NMRD in workers. Styrene is a fat-soluble chemical easily absorbed by multiple routes of exposure. Consistent with a possible role for styrene exposure and NMRD in workers, the respiratory epithelium lining airways is damaged by styrene inhalation at high concentrations and in susceptible animal models [Ohashi et al., 1986; Coccini et al., 1997; Cruzan et al., 1997 Cruzan et al., , 2013 . Detailed information on styrene toxicology is included in recent reviews [National Research Council, 2014; National Toxicology Program, 2014] .
MATERIALS AND METHODS
This review was completed using the steps recommended when conducting systematic reviews for occupational safety and health questions [Hempel et al., 2016] . Case reports, cross-sectional studies, and mortality studies on the respiratory health effects of exposure to styrene were identified through searching the published medical literature, reviewing relevant bibliographies, identifying manuscripts in the authors' collections, and obtaining unpublished data. A PubMed search of the scientific literature published from 1949 through October 8, 2015 was conducted. 1 An initial collection of 328 citations was retrieved (Fig. 1) . Seven duplicates were identified and excluded. The collection was then reduced by one author (RJN) to 41 articles by scanning titles and abstracts and excluding those not deemed relevant. Additional articles were sought from the selected manuscripts' bibliographies (n ¼ 16) and from the authors' collections (n ¼ 3), resulting in a total of 60 articles of interest. Five full-text articles were reviewed and excluded. Two unpublished case reports made available by two authors (KK, YTH) were also included in the analysis, for a total of 57 records of interest. Five relevant articles identified by the PubMed search but not in the English language were translated.
Study findings were summarized with respect to styrene exposures, spirometry measurements, clinical symptoms or signs, respiratory diagnoses as defined by the original study, or mortality from NMRD. Each crosssectional and mortality study was evaluated by two of the authors (RJN, JCG) for evidence of a potential association between styrene exposure and development of respiratory symptoms, airflow limitation, NMRD, or NMRD-related mortality. The evidence for positive association between styrene exposure and respiratory morbidity or mortality was characterized as strong, intermediate, or suggestive using a grading rubric developed by three of the authors (RJN, JCG, KK) (Table I) . Studies with no evidence were characterized as having no association.
1 Search strategy and keywords: 
RESULTS

Case Reports
In Table II , we summarize 13 articles describing 23 respiratory illness cases and two unpublished respiratory illness cases associated with styrene exposure [Moscato et al., 1987 [Moscato et al., , 1988 Hayes et al., 1991; Shields et al., 1995; Janigan et al., 1997; Occupational Safety and Health Research Institute, 2003; Fernandez-Nieto et al., 2006; Volkman et al., 2006; Ye et al., 2007; Chen et al., 2013; Cullinan et al., 2013; Lee et al., 2013; Arochena et al., 2014] . We reviewed an additional case series by Convery et al. [2001] that was not included in Table II or in the below summary analysis. In this case series, five coal miners and one automotive repairman who were diagnosed with occupational asthma and had exposure to styrene resins had negative inhalation challenges to styrene and were not classified as styrene-related cases, suggesting that styrene is not a non-specific trigger of hyperreactive airways.
In total, we identified nine OB cases, eight asthma cases, one hypersensitivity pneumonitis case, and one eosinophilic bronchitis case among workers exposed to styrene. We also included one case of non-occupational OB occurring in a man who burned polystyrene insulation and particle board in his home's wood burning stove [Janigan et al., 1997] . In addition, Shields et al. [1995] reported four cases of chronic dyspnea following a short-term exposure to styrene in a shared confined space. Another respiratory illness case occurred in a man who began having attacks of shortness of breath and wheezing 6 months after beginning work as a fiberglass painter in a yacht manufacturing plant; he had a severe mixed obstructive and restrictive pattern on spirometry (unpublished).
Of the 10 OB cases, the median age was 31.5 years (range: 25-51 years) at clinical presentation. The median time from first styrene exposure to respiratory symptom onset was 9.5 months (range: 4 hr-4 years), consistent with a short-latency disease. Only three cases were current smokers. Six cases occurred among workers in the boat manufacturing industry. One case occurred in a man after he assumed the job of another worker who had been diagnosed with OB and left his job following a lung transplant [Cullinan et al., 2013] . Five cases were known to have been diagnosed following pathologic analyses of open biopsy (n ¼ 4) and explanted tissue (n ¼ 1) specimens, and five cases were diagnosed based upon clinical findings. Two cases received lung transplants and two cases died (one from complications of a heart and lung transplant, and one from respiratory failure).
Of the eight asthma cases, the median age was 40 years (range: 30-50 years) at clinical presentation. Of the six cases with known time from first styrene exposure to respiratory symptom onset, the median time was 4 years (range: 1 month-20 years). Two cases occurred among workers in the automotive repair industry. Six cases had abnormal inhalational challenges to styrene. Of the six cases with known outcomes, five had improved or resolved symptoms after changing jobs and one died of respiratory failure after developing an acute asthma exacerbation within 2 hr of leaving work.
The four respiratory illness cases described by Shields et al. [1995] occurred among workers not previously exposed to styrene, following 3 months of working in a confined space with exposures to high styrene concentrations that led to neurotoxic effects, and without adequate respiratory protection. One of these cases occurred in a 23-year-old male who began having respiratory symptoms within 1 day of exposure. Worsening cough and respiratory symptoms led to his dismissal within 3 months of beginning his job. Two weeks after leaving his job he was hospitalized for pneumonia and developed acute respiratory distress syndrome. Six years after exposure, he had a forced vital capacity (FVC) of 61% of predicted, indicating chronic airways disease. He and the other three exposed workers suffered chronic dyspnea several years after the initial exposure, consistent with OB or other shortlatency and irreversible NMRD.
Cross-Sectional Studies
In Table III , we summarize 16 articles describing 15 cross-sectional studies evaluating the presence of respiratory symptoms, respiratory diagnoses, or airflow limitation among workers exposed to styrene [Chmielewski and Renke, 1975; Lorimer et al., 1976 Lorimer et al., , 1978 Harkonen, 1977; Axelson and Gustavson, 1978; Thiess and Friedheim, 1978; Jedrychowski and Fonte, 1984; Robins et al., 1990 ; Centers for Disease Control and Prevention (CDC), 1992; Lewin-Kowalik et al., Shields et al. [1995] 23 M Not reported 1day Case1of 4; exposed to high concentrations of styrene in confined space for 3 months; cough, sore throat; symptoms worsened after leaving job; hospitalized for pneumonia and acute respiratory distress syndrome 2 weeks after leaving job and 3.5 months after first exposure Ongoing respiratory symptoms 6 years after presentation, FVC 61% of predicted (Continued ) 1994; Tucek et al., 2002; Oner et al., 2004; Sati et al., 2011; Helal and Elshafy, 2013; McCague et al., 2015] . Studies of occupational cohorts varied considerably in size (range: 17-4,717 workers). Ten studies evaluated both respiratory symptoms/diagnoses and spirometry measurements, four spirometry measurements only, and one respiratory symptoms/diagnoses only. Twelve studies included a comparison group of the general population, unexposed workers, or workers exposed to lower concentrations of styrene. Thirteen of 15 studies had at least suggestive evidence of an association between styrene exposure and NMRD-related morbidity. One study had strong evidence. Eleven cross-sectional studies included respiratory symptoms or disease diagnoses. For the eight studies with comparison groups, seven reported a higher prevalence of !1 respiratory symptom or disease diagnosis among exposed workers. Symptoms reported at higher prevalence included cough, dyspnea, shortness of breath, wheeze, chest tightness, and recurrent lower respiratory symptoms. Diagnoses reported at higher prevalence included asthma, chronic bronchitis, and asthma or chronic bronchitis.
Fourteen studies reported spirometry measurements; of these, nine demonstrated airflow limitation among workers. Of the 12 studies with a comparison group, eight showed evidence of increased airflow limitation in the exposed groups compared with controls.
Mortality Studies
In Table IV , we summarize 25 articles describing 24 mortality studies of 13 occupational cohorts with 343-35,443 workers [Frentzel-Beyme et al., 1978; Nicholson et al., 1978; Ott et al., 1980; Meinhardt et al., 1982; Bond et al., 1985 Bond et al., , 1992 Hodgson and Jones, 1985; Okun et al., 1985; Coggon et al., 1987 Coggon et al., , 2015 Matanoski and Schwartz, 1987; (ii) recurrent wheeze or chest tightness: 5% (low-exposure), 12% (high-exposure), P < 0.01; (iii) acute lower respiratory symptoms for workers with low versus high exposure: 6%, 12%, NS (0.1^7.0 years of exposure); 8%, 25%, P < 0.02 (7.1^20.0); 8%, 18%, Upper respiratory symptoms, cough (i) 280 workers exposed to styrene; (ii) work-related respiratory symptoms (e.g., mucous membrane irritation, cough): exposed, 40%; controls, 20%; (iii) for both smokers and non-smokers, no significant differences in spirometric parameters for exposed versus controls þ Oner et al. [2004] Furniture manufacturing 47 Chest tightness, cough, dyspnea, wheezing (i) 5 (11%) workers with dyspnea, wheezing, chest tightness, or dry cough associated with styrene exposure; (ii) 3 of these 5 workers with occupational respiratory symptoms had positive methacholine challenges; of these 3 workers, 1had improvements in PEF when away from work and 0 had positive inhalation challenge to styrene þ Sati et al. [2011] Plastics manufacturing Not reported Styrene exposure in 3 of 10 plants included in study; exposure levels not reported NA CçOtt et al. [1980] Styrene-based product manufacturing (ii) low-exposure included workers who never worked in high exposure departments al., 1990; Wong, 1990; Cowles et al., 1994; Olsen et al., 1994; Wong et al., 1994; Welp et al., 1996; Sathiakumar et al., 1998; Wong and Trent, 1999; Marsh et al., 2001; Burns et al., 2003; Macaluso et al., 2004; Ruder et al., 2004; Sathiakumar and Delzell, 2009; Collins et al., 2013; Ruder et al., 2016] . Required tenure varied by study from !1 day to !5 years. Four studies required !6 months tenure and 13 required !1 year. Twelve studies provided at least suggestive evidence of an association between styrene exposure and NMRD-related mortality. Two studies had strong evidence. Mortality rates from NMRD for entire cohorts varied considerably. Four studies analyzing their entire cohorts indicated excess mortality from NMRD compared with the general population (see Supplementary Table SI for a listing of diagnostic codes used). Although OB can be misdiagnosed or classified as COPD on death certificates, only nine studies assessed COPD mortality (SMR [standardized mortality ratio] range: 0.85-1.35); of these, six studies assessing three cohorts reported excess mortality. The highest SMR for COPD was described by Ruder et al. [2016] and occurred among a cohort of boat builders in Washington State]. In this cohort, the SMR for COPD among workers characterized as having potentially high-exposure to styrene with tenure !1 year was 2.02 (95%CI, 1.08-3.46).
Because OB and asthma are short-latency diseases, they can occur in short-tenured workers. Thus, peak and perhaps average styrene exposures might be more important in the disease process than cumulative exposures. Only four studies analyzing two separate cohorts assessed NMRD-mortality among workers with tenure <1 year, and each indicated excess mortality. Wong [1990] investigated mortality for 15,908 reinforced plastics workers with tenure !6 months and reported the SMR from emphysema in workers with tenure 6 months-1 year was 1.28, although the results were not statistically significant. A later analysis of the same cohort indicated excess mortality for bronchitis, emphysema, and asthma (SMR, 1.96) and other NMRD (SMR 1.80) among workers with tenure 6 months-1 year, but again the results were not statistically significant [Wong et al., 1994; Wong and Trent, 1999] . Ruder et al. [2004] investigated mortality for workers with tenure <1 year and demonstrated an excess mortality from pneumoconiosis and other respiratory diseases (SMR, 2.78 [95%CI, . A later analysis of the same cohort determined the SMRs for respiratory system diseases among workers with tenure <1 year with high and low potential styrene exposures, respectively, were 1.99 (95%CI, 1.38-2.79) and 1.64 (95%CI, 0.96-2.63) [Ruder et al., 2016] .
Twelve studies found no positive association between styrene exposure and NMRD-related mortality. Of these, 10 required worker tenure !6 months, 10 did not specifically report COPD-related mortality, and nine did not separately assess workers with high-exposure.
Only two mortality studies required worker tenure !1 day, assessed workers by level of styrene exposure, and reported COPD-related mortality [Welp et al., 1996; Ruder et al., 2016] . Welp et al. [1996] studied a cohort of 35,443 reinforced plastics workers from 660 European factories. Workers with increasing time since first styrene exposure were more likely to have died from NMRD. Compared with the referents who worked <10 years, the relative risk (RR) (95%CI) for mortality from all respiratory diseases for working 10-19 years was 2.06 (1.20-3.54) and >20 years was 2.50 (1.28-4.89). Workers were also more likely to die from pneumonia with increasing average exposure. Compared with referents exposed to <60 ppm, the RR (95%CI) for pneumonia of those exposed to 60-119 ppm was 2.07 (0.53-8.04), 120-199 ppm was 3.20 (0.79-13.0), and >200 ppm was 6.10 (1. 44-25.8) . No association was found between mortality from bronchitis, emphysema, or asthma and time since first exposure, duration of exposure, average exposure, or cumulative exposure. In contrast, Ruder et al. [2016] described excess mortality for COPD among boat builders with high styrene exposures and tenure <1 year (SMR, 2.60 [95%CI, ) and !1 year 2.02 (95%CI, 1.08-3.46).
DISCUSSION
This review found evidence supporting that working in industries using styrene is a potential risk factor for NMRD, including: (i) 10 case reports of OB among persons exposed to styrene, including one case that occurred in a worker who replaced another worker diagnosed with OB, a highly unusual occurrence for a rare pulmonary disease; (ii) eight case reports of occupational asthma among workers exposed to styrene, including six with abnormal inhalation challenges to styrene; (iii) four cases of chronic dyspnea that occurred among workers who had a short-term exposure to high styrene levels in a shared confined space; (iv) 13 of 15 crosssectional studies of workers provided at least suggestive evidence of an association between styrene exposure and airflow limitation or NMRD; and (v) six of the nine mortality studies analyzing COPD indicated excess COPD-related mortality.
Obliterative Bronchiolitis
Mortality studies focusing on occupational cancer are not optimally designed to assess short-latency lung diseases, such as OB. The reviewed studies were mostly large, the cohorts were often followed for decades, and one-half required tenures !1 year. However, workers exposed to styrene might be at-risk for OB that occurs insidiously within weeks to months after beginning employment, but stabilizes once styrene exposure ends [Kreiss, 2013] , thus reducing the likelihood of detecting OB-related morbidity using mortality studies of cumulative exposures of long-tenured workers followed for decades for long-latency diseases. Indeed, eight (80%) of the 10 identified OB cases had respiratory symptom onset within 12 months of first exposure to styrene. Wong et al. demonstrated a higher SMR from other NMRD for workers with tenure <1 year, and Ruder et al. demonstrated a higher SMR from pneumoconiosis and other respiratory diseases, and COPD for workers with tenures <1 year [Wong, 1990; Wong et al., 1994; Wong and Trent, 1999; Ruder et al., 2004 Ruder et al., , 2016 . Moreover, Ruder et al. [2016] found a decreased SMR from respiratory system diseases for workers with high exposure when the cohort was limited to those with tenure !1 year (SMR, 1.64 [95%CI, 0.96-2.63]) compared with !1 day (SMR, 1.99 [95%CI, 1.38-2.79]). Additional studies that include short-term highexposures and short-tenured workers are required to better describe the risk of respiratory disease mortality among workers with styrene exposure.
An excess of COPD-related mortality was found in six of the nine mortality studies assessing COPD mortality. Although Collins et al. [2013] suggested an observed excess of COPD-related mortality in a cohort of U.S. reinforced plastics workers was likely because of greater tobacco use among those exposed, this hypothesis remains unexamined [Cummings et al., 2014] . The clinical manifestations of OB can be mistaken for those caused by asthma or COPD, which can lead to underreporting [CDC, 2013] . The absence of a medical diagnostic code for OB also increases the probability that deaths caused by OB were classified as COPD. These details raise the likelihood that at least some of the workers with causes of death listed as COPD died instead from OB.
A potential for classification of at least some OB cases as COPD among styrene-exposed workers is highlighted by Ruder et al. [2016] where the authors demonstrated a higher standardized rate ratio (SRR) for COPD between potentially high-and low-exposure styrene subcohorts (SRR, 1.76 [95%CI, ) than for lung cancer (SRR, 0.77 [95% CI, 0.42-1.41]), which suggests the additional mortality from COPD in this boatbuilding cohort is not easily attributable to smoking. Further investigation of current workers exposed to styrene who are diagnosed with COPD is warranted to examine the possibility for misdiagnosed OB.
Cross-sectional studies can provide unreliable estimates of the health of a cohort of workers because of the healthy worker effect [Shah, 2009] and likely underestimate the potential respiratory morbidity associated with styrene exposure as ill workers likely leave the workforce earlier.
Studies relying upon chest X-rays and spirometry measurements are further limited in their ability to detect workers with OB as neither diagnostic test is a sensitive indicator of disease, and pathologically confirmed cases can have obstructive, restrictive, or mixed spirometry patterns, or even normal spirometry measurements [Markopoulo et al., 2002; Kreiss, 2013; Cummings and Kreiss, 2015] . For example, a study of 38 U.S. soldiers returning from Iraq and Afghanistan who had insidious onset of dyspnea were found to have constrictive bronchiolitis following thoracoscopic lung biopsies; of those, 37 (97%) had normal chest X-rays, 32 (84%) had normal spirometry measurements, and only two (5%) had evidence of obstruction on spirometry [King et al., 2011] . Despite the lack of sensitivity of cross-sectional studies, over 86% of the studies we evaluated provided at least suggestive evidence that styrene was associated with NMRD-related morbidity.
Asthma
Similar to other volatile organic compounds [Nurmatov et al., 2015] , available evidence indicates that styrene is an asthmagen. Six published case reports of asthma demonstrated reduced FEV 1 following inhalation challenges with styrene among workers who suffered respiratory symptoms when exposed to styrene. Additionally, each of the five living asthma cases with known outcomes had improved or resolved symptoms after changing jobs and eliminating further styrene exposure. Clinical improvement following elimination of styrene exposure also makes it less likely these cases had OB, an irreversible lung disease.
The majority of cross-sectional studies provided evidence suggesting that styrene is a potential cause of occupational asthma. A cohort of U.S. styrene workers with higher exposure levels compared with those who had lower exposures had a higher prevalence of wheezing or chest tightness, and airflow obstruction [Lorimer et al., 1976 [Lorimer et al., , 1978 . Similarly, Polish workers exposed to styrene had a higher than expected prevalence of asthma and obstructive syndrome, and exposed non-smokers/ex-smokers were at higher risk of having airway obstruction compared with unexposed non-smokers/ex-smokers [Jedrychowski, 1982; Jedrychowski and Fonte, 1984] . Finally, Egyptian plastics workers compared with controls had reduced percent predicted FEV 1 and FVC, reduced mean FEV 1 /FVC percentage, and a negative correlation between blood styrene concentrations and both FEV 1 /FVC and maximal midexpiratory flow rates, an indicator of obstruction of the small airways (<2 mm internal diameter) [Helal and Elshafy, 2013] . Further investigation of styrene as an asthmagen is needed.
Challenges exist in assessing styrene's role in the development of NMRD as workers exposed to styrene are often exposed to multiple chemicals (Supplementary  Table SII ) [CDC, 2009] . Multiple chemical exposures likely occurred at all workplaces described in this review, but workers at glass reinforced plastics facilities where styrene exposures are highest likely were exposed to fewer chemicals than workers at other facilities [International Agency for Research on Cancer, 2002] . The possibility exists that styrene is a surrogate marker for another chemical exposure that causes an increase in NMRD-related morbidity and mortality among workers exposed to styrene. Interactions are also possible, as demonstrated by a study in mice showing the presence of biologically inert respirable glass fibers enhanced the respiratory toxicity of styrene in causing lower airway damage [Morisset et al., 1979] . The interpretation of published data with respect to exposures to styrene and other chemicals simultaneously was further complicated as exposures for facilities described in the literature reviewed here were often incomplete. Further animal studies would contribute to improved knowledge about the contribution of styrene to respiratory toxicity in the context of concurrent chemical exposures.
This analysis is subject to several limitations. First, considering the widespread global use of styrene across multiple industries, we identified only 25 cases of NMRD associated with exposure. However, the relatively small number of recognized cases might also be related to an underrecognition of both OB as clinical diagnosis and occupational causes of asthma. Second, available crosssectional studies for review might be biased toward studies reporting a positive association between styrene exposure and NMRD-related morbidity and mortality. Third, workers described in the case reports, cross-sectional studies, and mortality studies were exposed to often unknown or differing concentrations of styrene, had different lengths of exposure, and were exposed to multiple chemicals in the workplace, which potentially confounds the results of primary analyses. Fourth, this review included mortality studies that did not explicitly assess mortality from COPD, which could result in an underestimation of OB-related mortality. When COPD is included with other causes of NMRD, the possible effect of COPD is diluted by other diagnoses not associated with styrene exposure as demonstrated when examining only COPD-related mortality.
In summary, a review of available case reports, cross-sectional studies, and mortality studies suggested occupational exposure to styrene is a potential risk factor for NMRD, and related morbidity and mortality. This review highlighted the need for higher quality data. Additional animal exposure studies using novel humanized rodent models that better mimic human physiology would help address remaining questions regarding the development of lung disease following inhalational exposure to styrene. Additional studies should also include prospective and longitudinal investigations to further describe the risk for respiratory morbidity and mortality among short-and long-tenured workers in industries using styrene, both during and after employment, particularly for those with high styrene exposures. Finally, assessing for styrene and other chemical exposures in future epidemiologic studies could allow for added clarification of the influence styrene has on respiratory toxicity in workers with mixed chemical exposures.
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